JP2020527167A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020527167A5 JP2020527167A5 JP2020521498A JP2020521498A JP2020527167A5 JP 2020527167 A5 JP2020527167 A5 JP 2020527167A5 JP 2020521498 A JP2020521498 A JP 2020521498A JP 2020521498 A JP2020521498 A JP 2020521498A JP 2020527167 A5 JP2020527167 A5 JP 2020527167A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- viral vector
- composition according
- patient
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762529224P | 2017-07-06 | 2017-07-06 | |
| US62/529,224 | 2017-07-06 | ||
| PCT/US2018/040913 WO2019010301A1 (en) | 2017-07-06 | 2018-07-05 | TREATMENT OF CARDIOPATHIES BY INHIBITING THE ACTION OF PROTEINS FROM ANCHORING TO MUSCLE PROTEIN KINASES A (MAKAP) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020527167A JP2020527167A (ja) | 2020-09-03 |
| JP2020527167A5 true JP2020527167A5 (https=) | 2021-08-05 |
| JP7193874B2 JP7193874B2 (ja) | 2022-12-21 |
Family
ID=64904482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020521498A Active JP7193874B2 (ja) | 2017-07-06 | 2018-07-05 | 筋肉Ａキナーゼアンカータンパク質（ｍＡＫＡＰ）作用の阻害による心臓病の処置 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10907153B2 (https=) |
| EP (1) | EP3658157B1 (https=) |
| JP (1) | JP7193874B2 (https=) |
| AU (1) | AU2018297274B2 (https=) |
| CA (1) | CA3065816C (https=) |
| ES (1) | ES2958662T3 (https=) |
| WO (1) | WO2019010301A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9132174B2 (en) | 2013-03-15 | 2015-09-15 | Anchored Rsk3 Inhibitors, Llc | Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3) |
| WO2020051296A1 (en) * | 2018-09-06 | 2020-03-12 | Icahn School Of Medicine At Mount Sinai | Compositions and methods for the treatment of heart disease |
| CA3139974A1 (en) * | 2019-05-15 | 2020-11-19 | University Of Miami | Treatment of heart disease by disruption of the anchoring of pp2a |
| EP4103214B1 (en) | 2020-02-13 | 2026-04-29 | Tenaya Therapeutics, Inc. | Gene therapy vectors for treating heart disease |
| JP2026505638A (ja) * | 2023-02-13 | 2026-02-16 | シーアールアイ バイオテック，インコーポレイテッド | 心筋細胞における選択的発現のためのヒトトロポニンｔ遺伝子のプロモーター－エンハンサー配列 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6489125B1 (en) | 2000-05-10 | 2002-12-03 | The Trustees Of Columbia University In The City Of New York | Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor |
| AU2003295600A1 (en) * | 2002-11-14 | 2004-06-15 | Dharmacon, Inc. | Functional and hyperfunctional sirna |
| JP2007505158A (ja) * | 2003-05-21 | 2007-03-08 | ボード オブ リージェンツ ザ ユニバーシティー オブ テキサス システム | 心肥大および心不全の処置としてのプロテインキナーゼＣ−μ（ＰＫＤ）の阻害 |
| US9217155B2 (en) * | 2008-05-28 | 2015-12-22 | University Of Massachusetts | Isolation of novel AAV'S and uses thereof |
| US8734809B2 (en) * | 2009-05-28 | 2014-05-27 | University Of Massachusetts | AAV's and uses thereof |
| US20130136729A1 (en) | 2011-11-11 | 2013-05-30 | University of Virginia Patent Foundation, d/b/a University of Virginia Licensing & Ventures Group | Compositions and methods for targeting and treating diseases and injuries using adeno-associated virus vectors |
| US9132174B2 (en) * | 2013-03-15 | 2015-09-15 | Anchored Rsk3 Inhibitors, Llc | Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3) |
-
2018
- 2018-07-05 EP EP18827388.2A patent/EP3658157B1/en active Active
- 2018-07-05 US US16/028,004 patent/US10907153B2/en active Active
- 2018-07-05 ES ES18827388T patent/ES2958662T3/es active Active
- 2018-07-05 WO PCT/US2018/040913 patent/WO2019010301A1/en not_active Ceased
- 2018-07-05 AU AU2018297274A patent/AU2018297274B2/en active Active
- 2018-07-05 CA CA3065816A patent/CA3065816C/en active Active
- 2018-07-05 JP JP2020521498A patent/JP7193874B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020527167A5 (https=) | ||
| JP2022500066A5 (https=) | ||
| JP2023534037A5 (https=) | ||
| FI3807413T3 (fi) | Lihasspesifisen mikrodystrofiinin annostelu adeno-assosioituneella virusvektorilla lihasdystrofian hoitamiseksi | |
| RU2019100525A (ru) | Векторная система на основе аденоассоциированного вируса | |
| JP2021502060A5 (https=) | ||
| JP2020510428A5 (https=) | ||
| JP2016538885A5 (https=) | ||
| JP2019513779A5 (https=) | ||
| JP2022066336A5 (https=) | ||
| JP2019513389A5 (https=) | ||
| JP2019523648A5 (https=) | ||
| JP2018510620A5 (https=) | ||
| JP2018520646A5 (https=) | ||
| JP2014512171A5 (https=) | ||
| TW201629225A (zh) | 第九因子基因療法 | |
| JP2019515663A5 (https=) | ||
| JP2018537984A5 (https=) | ||
| RU2018137677A (ru) | Модифицированная промоторная система u6 для тканеспецифической экспрессии | |
| JP2021513866A5 (https=) | ||
| US20240002462A1 (en) | Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs | |
| JP2021533801A5 (https=) | ||
| JP2021510301A5 (https=) | ||
| JP2021534154A5 (https=) | ||
| JP2018509154A5 (https=) |